Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

NCT00004066 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Sarcoma
Small Intestine Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]